Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study. - Abstract - Europe PMC
Rivaroxaban noninferior to warfarin in patients with AF, bioprosthetic mitral valve: RIVER
Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery
Surgery | Thrombosis Adviser
Anticoagulation for Mechanical Heart Valves | Arteriosclerosis, Thrombosis, and Vascular Biology
RIVER Trial Presented at #AHA20 / Twitter
Comparison of phase III studies of apixaban, rivaroxaban, and... | Download Table
Characteristics of the optimal candidate for mechanical heart valve... | Download Scientific Diagram
![PDF] Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b848b4c36977bfee20ba4b3ed5bd220554206359/3-Figure1-1.png "PDF] Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study | Semantic Scholar")
PDF] Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study | Semantic Scholar
PDF) Initial experience with rivaroxaban in mechanical valve prosthesis in an animal model
Effectiveness and Safety of Off-label Dosing of Non–vitamin K Antagonist Anticoagulant for Atrial Fibrillation in Asian Patients | Scientific Reports
Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model | Arteriosclerosis, Thrombosis, and Vascular Biology
Valvular heart disease subanalyses of direct oral anticoagulant atrial... | Download Table
PLOS ONE: Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users
Optimal Anticoagulation After Tissue Aortic and Mitral Valve Replacement - Seminars in Thoracic and Cardiovascular Surgery
A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial - ScienceDirect
Antithrombotic Therapy in Patients With Valvular Heart Disease
Rivaroxaban Versus Warfarin in Patients with Mechanical Heart Valves: Open-Label, Proof-of-Concept trial—The RIWA study | SpringerLink
Usefulness and Safety of Rivaroxaban in Patients Following Isolated Mitral Valve Replacement With a Mechanical Prosthesis - American Journal of Cardiology
RIVER Trial Presented at #AHA20 / Twitter
Usefulness and Safety of Rivaroxaban in Patients Following Isolated Mitral Valve Replacement With a Mechanical Prosthesis - American Journal of Cardiology
AHA 2020: Rivaroxaban comparable to warfarin for patients with atrial fibrillation and prosthetic valves - Cardiovascular News
หนอนน้อยอ่านเปเปอร์ - Contraindications to the Use of Non–Vitamin K Oral Anticoagulants (ตามรูป) o Valvular atrial fibrillation (prosthetic valve, rheumatic mitral valvular disease, prior mitral valve repair) o Mechanical prosthetic heart valve o
